Results 211 to 220 of about 93,278 (240)

Human Respiratory Syncytial Virus

2016
openaire   +2 more sources

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

Lancet, The, 2022
You Li, Mauricio T Caballero, Daniel R Feikin   +2 more
exaly  

Human Respiratory Syncytial Virus Infections

2014
Marcello Lanari, Silvia Vandini, Giacomo Faldella   +2 more
openaire   +1 more source

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults

New England Journal of Medicine, 2023
Alberto A Papi, Mg Ison, Richard N Van Zyl-Smit   +2 more
exaly  

The Challenge of Respiratory Syncytial Virus Human Challenge Studies

New England Journal of Medicine, 2022
Larry J, Anderson, Edward E, Walsh
openaire   +2 more sources

Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study

New England Journal of Medicine, 2022
Philip R Dormitzer, Kena A Swanson
exaly  

Respiratory syncytial virus entry and how to block it

Nature Reviews Microbiology, 2019
Michael B Battles, Jason S Mclellan
exaly  

Human Respiratory Syncytial Virus

2008
openaire   +1 more source

[Illnesses by the human respiratory syncytial virus].

Medizinische Monatsschrift fur Pharmazeuten, 2006
Human respiratory syncytial virus (HRSV) is a single-stranded, enveloped RNA virus of the Paramyxoviridae family. Worldwide, HRSV represents the leading cause of respiratory tract infections in infants and young children. Approximately up to 70% of infants are infected during their first year of life.
openaire   +1 more source

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

Lancet, The, 2017
Ting Shi, Eric A F Simões, Shabir A Madhi   +2 more
exaly